2015, Number 1
Pertussis epidemiological behavior in Colombia
Full text
Language: Spanish
References: 14
Page: 42-51
PDF size: 149.62 Kb.
ABSTRACT
Introduction: pertussis is an event mandatory to be reported in public health in Colombia. The diagnosis is made by laboratory through the implemented techniques of direct immuno-fluorescence, Polymerase chain reaction culture, in addition to clinical confirmation, and if epidemiologic investigation of outbreaks.Objectives: observe the behavior of both the notification and confirmation of pertussis cases in 2012 in Colombia, to provide tools for comparative analysis of identified cases this year in other regions, and identify possible factors that prevented the timely and adequate collection thereof.
Methods: a retrospective descriptive analysis was performed of the notification in Colombia during 2012 and the results of laboratory Microbiology Group at the National Institute of Health, laboratories in Antioquia, Nariño and the District of Bogotá.
Results: in 2012, 11 332 cases were reported by SIVIGILA application and 56.3% by laboratory, 22.5% by clinical and 21.2% were confirmed by epidemiological link. The incidence in the general population was 8.5 cases per 100 000 inhabitants; in the population younger than five years, the incidence was 61.7 cases per 100 000 children under five years and in children younger than one year, it was 255.6 cases per 100 000 children younger than a year. 74 deaths occurred in the country, representing a fatality rate of 1.9%. Out of the 46 outbreaks of pertussis, one was in the indigenous community, in which two deaths were confirmed by epidemiological link.
Conclusions: the pertussis overall incidence was 8.5 cases per 100,000 inhabitants, the highest in 25 years; also the number of deaths exceeded those presented during 2004-2011 (70 deaths).
REFERENCES
Abarca K, Valdivieso R, Potin M, Ibáñez I, Vial P. Inmunogenicidad y reactogenicidad de una vacuna de difteria, tétanos, pertussis acelular de contenido antigénico reducido (dTpa) en niños de 10 a 11 años de edad y en adultos Scientific Electronic Library [Online]. [Actualizado May 2002; citado 20 Oct 2012];130(5). Disponible en: http://wwwscielocl/scielophp?script=sci_arttext&pid=S0034- 98872002000500004
Olivares J, Bueno M. Tos ferina: revisión clínica a propósito de un caso. Revista Pediatría Atención Primaria Scientific Electronic Library [Online]. [Actualizado Dic 2011; citado 20 Oct 2012];13(52). Disponible en: http://scieloisciiies/scielophp?script=sci_arttext&pid=S1139- 76322011000600007&lang=pt
Centers for Disease Control and Prevention Vaccines and Inmunitazions Pertussis Epidemiology and Prevention of Vaccines-Preventable Diseases. The Pink Book: Course Textbook – 12th Edition Second Printing. May 2012 [consultado 07 Sep 2014]. Disponible en: http://wwwcdcgov/vaccines/pubs/pinkbook/perthtml#complications
Sawal M, Cohen M, Irazuzta J, Kumar R, Kirton C, Brundler M, et al. H Klonin Fulminant Pertussis: A Multi-Center Study Whith New Insights Into the Clinico- Pathological Mechanisms Wiley Online Libary Pediatric Pulmonlogy 2009 [actualizado Mar 2014; citado 07 Sep 2014];44:970-80. Disponible en: http://onlinelibrarywileycom/doi/101002/ppul21082/abstract
Instituto Nacional de Salud Grupo de Enfermedades Transmisibles Equipo Inmnoprevenibles. Protocolo de Vigilancia en Salud Pública Tos Ferina. [Actualizado Mar 2014; citado 07 Sep 2014]. Disponible en: http://wwwinsgovco/lineas-deaccion/ Subdireccion- Vigilancia/sivigila/Protocolos%20SIVIGILA/PRO%20Tos%20ferinapdf